Is Job Security Throwing You Off Balance? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Is Job Security Throwing You Off Balance?
Results from Pharmaceutical Technology's Annual Employment Survey


Pharmaceutical Technology
Volume 32, Issue 12, pp. 38-44

Salary and benefits

Overall results. The mean base annual salary was $85,087 for all respondents, which is down from an average of $90,059 in 2007 and from the 2006 average of $88,729. Employees working in the US earned an average of $98,203. Overall, employees reported an average of $10,892 in additional income from their principal employer, including bonuses, summer work, and grants, and an average of $1808 in additional income from other professional work.


Figure 3: Annual salaries of men and women.
Salary according to gender only. There continues to be a $20,000 gap between men's and women's average salaries. Overall, women reported an annual base salary of $70,031 (women working in the US earned an average of $84,374). Male employees earned $91,306 in compensation overall, and men in the US earned $105,878 on average (see Figure 3).


Figure 4: Salary according to job function.
Salary according to job function. Jobs in drug metabolism, production management, technology transfer, engineering, pharmaceutical development, and computer information systems were the top-earning fields this year, with the first three each reporting an average of more than $100,000 (see Figure 4). Employees working in education, preformulation, and drug delivery reported the lowest average annual salaries.


Figure 5: Salary according to region.
Salary according to location. On average, employees in Northeastern and Southwestern states earned the highest salaries (see Figure 5). These regions also had the greatest number of respondents. Respondents from the Northwest reported the lowest average salaries, but also were the smallest group.


Table III: Percentage of respondents receiving the following employer-provided benefits.
Benefits. Table III lists the most common benefits granted. A majority of employees indicated receiving health and life insurance as well as pension benefits and reimbursement for training. These numbers are significantly lower than those from last year, perhaps because of the increased number of respondents who worked outside the US.


Figure 6: Mean annual base salaries since 1998.
On average, employees are granted 13 paid public holidays and 20 paid vacation days, although most took only 17 of these days for vacation and admitted to doing some work (e.g., checking email, returning calls) for at least 5 of these days (one more day than last year).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here